Datametrex Sees Request To Increase Testing By 300% Due To Surging Cases
Datametrex AI (TSXV: DM) is expected to see its health division grow as a result of the exploding cases of
Read more
Healthcare
Telecure Sees CEO Resign After Unauthorized Termination Of COO
It appears the outright embarrassing events over at Telecure Technologies (CSE: TELE) have finally come to a head. The firm
Read more
Mind Medicine Sees Final Co-Founder Leave The Company
Mind Medicine (NEO: MMED) appears to now be fully under new management. On Friday evening, after the close of markets,
Read more
Empower Closes $3.0 Million Financing, CEO Enters Into Share Loan Arrangement
Empower Clinics (CSE: CBDT) has evidently closed a much-needed financing as of last night. The financing consisted of both units
Read more
dentalcorp Releases Q4 Preliminary Figures, Announces $100 Million Bought Deal
It was a rather eventful evening for dentalcorp (TSX: DNTL) last night, whom announced a large bought deal financing, while
Read more
KetamineOne Reports Fiscal Q1 2022 Financials: $2.0 Million In Revenue
KetamineOne Capital (NEO: MEDI) released this morning its financial reports for the fiscal quarter ended October 31, 2021. The firm managed
Read more
Cognetivity Looks To Raise $3.0 Million To Fund US Expansion
Cognetivity Neurosciences (CSE: CGN) is looking to close out the year with a capital raise. The firm last night indicated
Read more
Datametrex Secures Rights To New PCR Test Kit
Datametrex AI (TSXV: DM) continues to develop out its healthcare division focused on COVID-19 testing. The firm this morning revealed
Read more
TeleCure Fires Executive For “Microaggression”
The world of small cap continues to amaze. It was announced this evening that TeleCure Technologies (CSE: TELE) has fired
Read more
Ventripoint Receives Further Funding From National Research Council of Canada
Ventripoint Diagnostics (TSXV: VPT) this morning had a brief release, indicating the firm has received further research funding. The latest
Read more